{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:47:02Z","timestamp":1760057222842,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ajem.2020.03.059","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T19:33:33Z","timestamp":1585769613000},"page":"2723-2726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Levosimendan with other inotropes or vasopressors: Should you combine them?"],"prefix":"10.1016","volume":"38","author":[{"given":"Gon\u00e7alo J.L.","family":"Cunha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.L.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita V.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00facia","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e2ndida","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.ajem.2020.03.059_bb0005","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ajem.2020.03.059_bb0010","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/CCM.0b013e3181809846","article-title":"Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction","volume":"36","author":"Fuhrmann","year":"2008","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.ajem.2020.03.059_bb0015","first-page":"2732","article-title":"Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock","volume":"35","author":"Russ","year":"2007","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.ajem.2020.03.059_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/17482940802262376","article-title":"The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study","volume":"10","author":"Rossinen","year":"2008","journal-title":"Acute Card Care"},{"issue":"2","key":"10.1016\/j.ajem.2020.03.059_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"17","key":"10.1016\/j.ajem.2020.03.059_bb0030","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA."},{"issue":"5","key":"10.1016\/j.ajem.2020.03.059_bb0035","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5603\/CJ.2011.0009","article-title":"Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure","volume":"18","author":"Lunghetti","year":"2011","journal-title":"Cardiol J"},{"issue":"8","key":"10.1016\/j.ajem.2020.03.059_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071659","article-title":"The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis","volume":"8","author":"Pirracchio","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ajem.2020.03.059_bb0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13054-016-1387-1","article-title":"Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality","volume":"20","author":"Tarvasm\u00e4ki","year":"2016","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.ajem.2020.03.059_bb0050","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jcrc.2013.06.014","article-title":"Levosimendan: a retrospective single-center case series","volume":"28","author":"Berry","year":"2013","journal-title":"J Crit Care"},{"issue":"10","key":"10.1016\/j.ajem.2020.03.059_bb0055","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.amjcard.2004.07.128","article-title":"Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone","volume":"94","author":"Nanas","year":"2004","journal-title":"Am J Cardiol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720302151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720302151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:51:54Z","timestamp":1760025114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675720302151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0735675720302151"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2020.03.059","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levosimendan with other inotropes or vasopressors: Should you combine them?","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2020.03.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}